
STAAR Surgical Company STAA
$ 23.09
-0.52%
Quarterly report 2025-Q3
added 11-05-2025
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
49.1 M |
Market Cap[1] |
$ 1.13 B |
EBITDA (LTM) |
$ -35.4 M |
P/E (LTM) |
-21.76 |
P/S (LTM) |
4.19 |
EPS (LTM) |
-1.06 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
$ 19.11 | -0.98 % | $ 9.75 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 194.07 | -0.8 % | $ 55.8 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 8.64 | -18.34 % | $ 174 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 0.67 | 1.66 % | $ 28.4 M | Nasdaq Global Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Alcon
ALC
|
$ 78.81 | -0.64 % | $ 40.4 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 5.81 | 2.11 % | $ 265 M | Nasdaq Capital Market | ||
|
AtriCure
ATRC
|
$ 39.56 | -1.54 % | $ 1.86 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 142.67 | -1.36 % | $ 3.48 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 4.49 | -3.55 % | $ 24.8 K | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 177.44 | -0.63 % | $ 5.54 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.84 | -1.23 % | $ 525 M | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.96 | -0.62 % | $ 16.3 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 112.91 | -1.16 % | $ 5.47 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 81.1 | -2.3 % | $ 1.82 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 80.15 | -1.02 % | $ 4.03 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.97 | 0.67 % | $ 185 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 130.06 | -0.77 % | $ 6.93 B | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 88.14 | -0.47 % | $ 5.13 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.42 | -2.02 % | $ 180 M | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 566.36 | -1.09 % | $ 201 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.0 | -2.44 % | $ 20.4 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.27 | -0.22 % | $ 21.5 M | NYSE American | ||
|
Nephros
NEPH
|
$ 4.88 | 3.39 % | $ 50.7 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 2.3 | -0.22 % | $ 186 M | NYSE American | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 21.71 | -0.91 % | $ 3.74 B | NYSE | ||
|
STERIS plc
STE
|
$ 253.52 | -0.76 % | $ 25 B | NYSE,SPB | ||
|
Pro-Dex
PDEX
|
$ 38.48 | -0.3 % | $ 127 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 32.4 M | Nasdaq Capital Market | ||
|
Pulse Biosciences
PLSE
|
$ 13.73 | 0.22 % | $ 660 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 55.96 | -0.57 % | $ 203 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 240.87 | -0.91 % | $ 35.2 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.43 | 0.35 % | $ 2.32 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 163.86 | -1.64 % | $ 9.13 M | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 24.18 | -1.95 % | $ 1.11 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.77 | -0.63 % | $ 23.1 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 122.04 | 0.35 % | $ 5.72 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 275.14 | -0.62 % | $ 20.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.